Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 1283)
Posted On: 03/30/2020 10:46:58 PM
Post# of 153900
Avatar
Posted By: Bored Lawyer
Re: LongPennyPincher #24232
RE:. Cost for Leronlimab in CV indication...

A member of my investment group pointed this out to me today. Let's remember that the costs that we have been quoted are annual costs, but most CV patients will need the drug for maximum of 6 weeks (I believe according to the trial protocol).

So a $60,000 annual cost becomes a $7000 treatment per CV patient.

This also helps with the supply issues we've discussed.

Ultimately, CV may not be a huge profit center for CYDY, but it may serve to put the company on the map finally and advance the HIV and cancer indications at warp speed.

Wow, what a roller coaster this is going to be...













(7)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site